CC
Overvalued by 125.7% based on the discounted cash flow analysis.
Market cap | $2.41 Billion |
---|---|
Enterprise Value | $2.40 Billion |
Dividend Yield | $0.68 (4.18%) |
Earnings per Share | $0.58 |
Beta | 1.63 |
Outstanding Shares | 150,238,691 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -5.77 |
---|---|
PEG | 0.9 |
Price to Sales | 0.41 |
Price to Book Ratio | 16.13 |
Enterprise Value to Revenue | 0.41 |
Enterprise Value to EBIT | -25.81 |
Enterprise Value to Net Income | -6 |
Total Debt to Enterprise | 0.2 |
Debt to Equity | 2.06 |
No data
No data
The Chemours Company is a global leader in Titanium Technologies, Fluoroproducts, and Chemical Solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemi...